Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Loading metrics

Open Access

Correction

Correction: Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan

Hitoshi Tajiri,
Satoshi Motoya,
Fukunori Kinjo,
Atsuo Maemoto,
Takayuki Matsumoto,
Noriko Sato,
Hiroshi Yamada,
Mieko Nagano,
Yutaka Susuta,
Kunihiko Ozaki,
Kazuoki Kondo,
Toshifumi Hibi

Correction: Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan

Hitoshi Tajiri,
Satoshi Motoya,
Fukunori Kinjo,
Atsuo Maemoto,
Takayuki Matsumoto,
Noriko Sato,
Hiroshi Yamada,
Mieko Nagano,
Yutaka Susuta,
Kunihiko Ozaki

x

Published: April 19, 2022
https://doi.org/10.1371/journal.pone.0261932

Reader Comments (0)

Post a new comment on this article